TRAD CHI MED(00570),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

00570 TRAD CHI MED

Not Yet Opened 05-29 16:08:26

1.560

+0.030

+1.96%

High1.570	Low1.530	Vol15.56M
Open1.540	D1 Closing1.530	Amplitude2.61%
Mkt Cap7.86B	Tradable Cap7.86B	Total Shares5.04B
T/O24.19M	T/O Rate0.31%	Tradable Shares5.04B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"00570","market":"HK","secType":"STK","nameCN":"TRAD CHI MED","latestPrice":1.56,"timestamp":1780042106002,"preClose":1.53,"halted":0,"volume":15562000,"delay":0,"changeRate":0.01960784313725492,"floatShares":5035801852,"shares":5035801852,"eps":-0.0679,"marketStatus":"Not Yet Opened","change":0.03,"latestTime":"05-29 16:08:26","open":1.54,"high":1.57,"low":1.53,"amount":24190780,"amplitude":0.026144,"askPrice":1.56,"askSize":344000,"bidPrice":1.55,"bidSize":96000,"shortable":3,"etf":0,"ttmEps":-0.07559,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1780277400000},"marketStatusCode":0,"adr":0,"listingDate":734112000000,"exchange":"SEHK","adjPreClose":1.53,"dividendRate":0.002224,"openAndCloseTimeList":[[1780018200000,1780027200000],[1780030800000,1780041600000]],"volumeRatio":1.4351913531010916,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00570/tweets","defaultTab":"tweets","newsList":[{"id":"1173566561","title":"TRAD CHI MED Sets 26 June 2026 AGM to Review 2025 Results, Re-elect Directors and Renew Auditor","url":"https://stock-news.laohu8.com/highlight/detail?id=1173566561","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173566561?lang=en_us&edition=fundamental","pubTime":"2026-05-29 17:27","pubTimestamp":1780046826,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED) will convene its Annual General Meeting on 26 June 2026 at 2:30 p.m. in the Conference Room, 4th Floor, Winteam Plaza, 6 Kuiqi...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186365192","title":"TRAD CHI MED Publishes AGM Circular and Confirms Transition to Full Electronic Corporate Communications","url":"https://stock-news.laohu8.com/highlight/detail?id=1186365192","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186365192?lang=en_us&edition=fundamental","pubTime":"2026-05-29 17:24","pubTimestamp":1780046698,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED) has released its latest corporate communications package, which includes the circular and notice for the 2026 Annual General...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197317183","title":"TRAD CHI MED Sets 26 Jun 2026 AGM and Formalises Full E-Communication for Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=1197317183","media":"Bulletin Express","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197317183?lang=en_us&edition=fundamental","pubTime":"2026-05-29 17:23","pubTimestamp":1780046607,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings Co. Limited (TRAD CHI MED) has released its circular, meeting notice and proxy form for the 2026 annual general meeting, scheduled for 2:30 p.m. on 26 June...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111171563","title":"China Traditional Chinese Medicine Announces Board Reshuffle: Liu Haijian Resigns, Chen Kun Appointed as Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1111171563","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111171563?lang=en_us&edition=fundamental","pubTime":"2026-05-15 17:42","pubTimestamp":1778838167,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings Co. Limited confirmed that Non-Executive Director Liu Haijian resigned with immediate effect on 15 May 2026 due to a change in work arrangements. Liu also...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113426306","title":"TRAD CHI MED Announces Board Reshuffle: Chen Kun Appointed as Non-Executive Director and Committee Member","url":"https://stock-news.laohu8.com/highlight/detail?id=1113426306","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113426306?lang=en_us&edition=fundamental","pubTime":"2026-05-15 17:40","pubTimestamp":1778838030,"startTime":"0","endTime":"0","summary":"The board of directors of TRAD CHI MED (00570) passed a resolution on May 15, 2026, announcing a change in its composition. Mr. Liu Haijian has resigned from his position as a non-executive director...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1191","00570","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635700383","title":"China Traditional Chinese Medicine Holdings files directors list with Hong Kong exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2635700383","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635700383?lang=en_us&edition=fundamental","pubTime":"2026-05-15 17:37","pubTimestamp":1778837861,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings filed an updated list of directors with Hong Kong Stock Exchange dated May 15, 2026.Board led by Chairman Yang Jun, with executive directors Li Hongjian, Peng Li.Non-executive directors include Li Xiangrong, Zu Jing, Xu Jinghui, Chen Kun, Huang Hao.Independent non-executive directors include Xie Rong, Yu Zishan, Qin Ling, Li Weidong.Board committees maintained across audit, remuneration and appraisal, nomination, strategy; Yang chairs nomination, strategy, while Xie chairs audit, Qin chairs remuneration and appraisal.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Traditional Chinese Medicine Holdings Co. Limited published the original content used to generate this news brief via IIS, t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL3r1cXq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","00570","BK1515","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635700828","title":"China Traditional Chinese Medicine names Chen Kun as non-executive director","url":"https://stock-news.laohu8.com/highlight/detail?id=2635700828","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635700828?lang=en_us&edition=fundamental","pubTime":"2026-05-15 17:35","pubTimestamp":1778837731,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings named Chen Kun as non-executive director, effective May 15, 2026.Chen also joined board remuneration and appraisal committee; he joined Sinopharm Group in November 2019, previously served as deputy secretary of its discipline inspection commission, later held roles at China National Biotec Group as discipline inspection secretary and party committee member.Liu Haijian resigned as non-executive director, effective immediately on May 15, 2026; he also stepped down from board remuneration and appraisal committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Traditional Chinese Medicine Holdings Co. Limited published the original content used to generate this news brief via IIS, the Issue","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL4Lk2Xk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1197","01099","LU1115378108.SGD","BK1500","BK1191","BK1606","LU0640798160.USD","00570","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157669200","title":"TRAD CHI MED's Subsidiaries Gain Approval for Two Classical Herbal Formulations in Granule Form","url":"https://stock-news.laohu8.com/highlight/detail?id=1157669200","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157669200?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:08","pubTimestamp":1778494099,"startTime":"0","endTime":"0","summary":"TRAD CHI MED (00570) has announced that its subsidiaries, China National Pharmaceutical Group Guangdong Global Pharmaceutical Co., Ltd. and Guangdong Yifang Pharmaceutical Co., Ltd., have each...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570","BK1606","BK1191","BK1515","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152416437","title":"China Traditional Chinese Medicine (China TCM) wins NMPA nod for two ancient-formula granules","url":"https://stock-news.laohu8.com/highlight/detail?id=1152416437","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152416437?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:03","pubTimestamp":1778493811,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings Co. Limited (China TCM) has obtained formal marketing approval from the National Medical Products Administration (NMPA) for two Category 3.1 traditional...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634407834","title":"China TCM wins China approval for Shaoyao Gancao Tang granules","url":"https://stock-news.laohu8.com/highlight/detail?id=2634407834","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634407834?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:00","pubTimestamp":1778493632,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings received National Medical Products Administration registration certificates for two 3.1-category classic TCM compound granules, Shaoyao Gancao Tang Granules, Taohes Chengqi Tang Granules, clearing them for commercial launch.Approvals cover products developed by subsidiaries Sinopharm Group Guangdong Global Pharmaceutical, Guangdong Yifang Pharmaceutical.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Traditional Chinese Medicine Holdings Co. Limited published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on May 11, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLbTrZ8y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0154","BK1606","BK0196","LU0640798160.USD","BK0185","01099","BK1197","BK0098","BK0028","BK1500","BK0268","SG9999006597.SGD","00570","BK0267","BK1191","LU1115378108.SGD","BK0183","BK0188","SG9999003461.SGD","BK0012","BK1515","BK0094","600373"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634402702","title":"China Traditional Chinese Medicine Holdings - Receives Drug Approval Licenses From China National Medical Products Administration","url":"https://stock-news.laohu8.com/highlight/detail?id=2634402702","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634402702?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:00","pubTimestamp":1778493626,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nFWN41N058:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00570","BK1606","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634140207","title":"China Traditional Chinese Medicine Holdings - Shaoyao Gancao Tang and Taohe Chengqi Tang Granules Approved for Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2634140207","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634140207?lang=en_us&edition=fundamental","pubTime":"2026-05-11 18:00","pubTimestamp":1778493626,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nFWN41N058:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1515","BK1191","BK1606","00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162860524","title":"TRAD CHI MED Announces 2025 Annual Report Release and Transition to Full E-Communication","url":"https://stock-news.laohu8.com/highlight/detail?id=1162860524","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162860524?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:45","pubTimestamp":1777373146,"startTime":"0","endTime":"0","summary":"On 29 April 2026, China Traditional Chinese Medicine Holdings Co. Limited (“TRAD CHI MED”) published its 2025 Annual Report. English and Chinese versions are available on both the company website...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630189308","title":"China TCM issues 2025 ESG report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630189308","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630189308?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:40","pubTimestamp":1777372822,"startTime":"0","endTime":"0","summary":"China TCM released its 2025 ESG report, outlining priorities in R&D, supply chain, green operations, inclusive wellbeing.R&D spending totaled RMB 511.47 million, supported by 54 provincial-or-higher research platforms.Environmental protection investment reached RMB 19.57 million, with no major environmental incidents reported.GAP-certified herb sourcing expanded to 31 varieties across 35,800 mu, with total production base area at 545,200 mu.Anti-corruption training coverage held at 100%, with no corruption-related lawsuits recorded during 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Traditional Chinese Medicine Holdings Co. Limited published the original content used to generate this news brief via IIS, the Issuer Informa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL9FYnXf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","00570","BK1606","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126014307","title":"中药控股聚焦核心业务转型：2025年营收147.44779亿元，同比降10.7%，净亏4.5809亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126014307","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126014307?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:31","pubTimestamp":1777372301,"startTime":"0","endTime":"0","summary":"根据中国中药控股有限公司（下称“中药控股”）发布的年度报告内容显示，公司于2025财政年度实现营业收入约人民币147.44779亿元（2024年同期为165.09708亿元），同比下降10.7%。受集中采购持续推进及市场竞争加剧影响，公司由2024年的盈利转为亏损，年内录得归属于公司股东的亏损约人民币3.4207亿元，全年合并亏损则达4.5809亿元，经营表现承压。 在分部业务方面：①...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"中药控股聚焦核心业务转型：2025年营收147.44779亿元，同比降10.7%，净亏4.5809亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630145370","title":"China Traditional Chinese Medicine publishes 2025 annual report","url":"https://stock-news.laohu8.com/highlight/detail?id=2630145370","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630145370?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:30","pubTimestamp":1777372225,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings released its annual report for year ended Dec. 31, 2025, highlighting a strategic reset that weighed on results as it cleared legacy issues and exited non-core activities.Revenue fell 10.7% to RMB 14.74 billion, driven by weaker concentrated TCM granules demand and pricing pressure tied to centralized procurement.TCM decoction pieces held steady, supported by stronger medical-terminal mix and broader participation in national procurement programs.Finished drugs shifted toward hospital coverage expansion and branded e-commerce rollout to offset softer offline pharmacy momentum.Chairman’s outlook framed 2026 as start of a new cycle focused on core segments, supply-chain integration, and product innovation to rebuild profitability.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational pu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL22CNfS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","BK1606","00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199556992","title":"China TCM’s 2025 ESG Report: RMB 511.47 Million R&D Outlay, 2.65% CO₂-Intensity Cut and Expanded Green Factory Network","url":"https://stock-news.laohu8.com/highlight/detail?id=1199556992","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199556992?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:24","pubTimestamp":1777371873,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings Co. Limited (“China TCM”) has published its 10th standalone Environmental, Social and Governance (ESG) Report, detailing performance for the year ended 31...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129292789","title":"Stock Track | China Traditional Chinese Medicine Plummets 5.32% Intraday After Swinging to Loss in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=1129292789","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129292789?lang=en_us&edition=fundamental","pubTime":"2026-03-23 14:59","pubTimestamp":1774249151,"startTime":"0","endTime":"0","summary":"Shares of China Traditional Chinese Medicine (TRAD CHI MED) plummeted 5.32% during intraday trading on Monday, reflecting a sharp decline in investor confidence.The drop follows the company's recent...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["00570"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621724300","title":"China Traditional Chinese Medicine Swings to Loss in 2025; Shares Fall 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621724300","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621724300?lang=en_us&edition=fundamental","pubTime":"2026-03-23 13:32","pubTimestamp":1774243925,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine  posted a loss attributable to owners of 342.1 million yuan for 2025, compared with a profit of 54.1 million yuan a year earlier, according to a March 20 Hong Kong bourse filing.Shares of the medicine firm fell nearly 4% in Monday afternoon trade.Loss per share came in at 0.0679 yuan, compared with earnings of 0.0107 yuan a year earlier.Revenue declined year on year to 14.7 billion yuan from 16.5 billion yuan.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["00570","BK1191","BK1515","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621791718","title":"China Traditional Chinese Medicine (SEHK:570) Half Year Loss Challenges Turnaround Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2621791718","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621791718?lang=en_us&edition=fundamental","pubTime":"2026-03-22 03:09","pubTimestamp":1774120142,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine Holdings (SEHK:570) has reported its FY 2025 first half results with revenue of C¥7.5b and a basic EPS loss of C¥0.02, while the trailing twelve months show revenue of C¥14.7b and a basic EPS loss of C¥0.07. Over recent half year periods, revenue has moved from C¥8.4b with EPS of C¥0.04 in 1H 2024 to C¥8.1b with an EPS loss of C¥0.03 in 2H 2024, then to C¥7.5b with an EPS loss of C¥0.02 in 1H 2025, setting up a story where investors are weighing weaker...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-570/china-traditional-chinese-medicine-holdings-shares/news/china-traditional-chinese-medicine-sehk570-half-year-loss-ch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-570/china-traditional-chinese-medicine-holdings-shares/news/china-traditional-chinese-medicine-sehk570-half-year-loss-ch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1515","00570","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.china-tcm.com.cn","stockEarnings":[{"period":"1week","weight":-0.025},{"period":"1month","weight":-0.0824},{"period":"3month","weight":-0.2277},{"period":"6month","weight":-0.3305},{"period":"1year","weight":-0.2529},{"period":"ytd","weight":-0.2536}],"compareEarnings":[{"period":"1week","weight":-0.0165},{"period":"1month","weight":-0.0356},{"period":"3month","weight":-0.0544},{"period":"6month","weight":-0.0262},{"period":"1year","weight":0.0683},{"period":"ytd","weight":-0.0175}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"China Traditional Chinese Medicine Holdings Co. Limited is principally engaged in the manufacture and sales of traditional Chinese medicine (TCM). The Company operates through 12 subsidiaries, including Sinopharm Group Dezhong (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Pharmaceutical Co., Ltd., Sinopharm Group Guangdong Medi-World Pharmaceutical Co., Ltd., Sinopharm Group Luya (Shandong) Pharmaceutical Co., Ltd., Sinopharm Group Feng Liao Xing (Foshan) Medicinal Material & Slices Co., Ltd., Foshan Winteam Pharmaceutical Sales Company Limited, Sinopharm Group Tongjitang (Guizhou) Pharmaceutical Co., Ltd., Sinopharm Group Jingfang (Anhui) Pharmaceutical Co., Ltd., Sinopharm Group Longlife (Guizhou) Pharmaceutical Co., Ltd., Qinghai Pulante Pharmaceutical Co., Ltd., Guizhou Zhongtai Biological Technology Company Limited and its subsidiaries and Jiangyin Tianjiang Pharmaceutical Co., Ltd. and its subsidiaries.","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":-0.00955},{"month":2,"riseRate":0.666667,"avgChangeRate":0.108445},{"month":3,"riseRate":0.333333,"avgChangeRate":0.008801},{"month":4,"riseRate":0.393939,"avgChangeRate":0.016282},{"month":5,"riseRate":0.558824,"avgChangeRate":0.076578},{"month":6,"riseRate":0.424242,"avgChangeRate":-0.017354},{"month":7,"riseRate":0.484848,"avgChangeRate":0.001624},{"month":8,"riseRate":0.363636,"avgChangeRate":0.000838},{"month":9,"riseRate":0.515152,"avgChangeRate":-0.020412},{"month":10,"riseRate":0.484848,"avgChangeRate":-0.01946},{"month":11,"riseRate":0.454545,"avgChangeRate":0.032},{"month":12,"riseRate":0.454545,"avgChangeRate":0.006851}],"exchange":"SEHK","name":"TRAD CHI MED","nameEN":"TRAD CHI MED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TRAD CHI MED(00570),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TRAD CHI MED(00570) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TRAD CHI MED,00570,TRAD CHI MED股票,TRAD CHI MED股票老虎,TRAD CHI MED股票老虎国际,TRAD CHI MED行情,TRAD CHI MED股票行情,TRAD CHI MED股价,TRAD CHI MED股市,TRAD CHI MED股票价格,TRAD CHI MED股票交易,TRAD CHI MED股票购买,TRAD CHI MED股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TRAD CHI MED(00570),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TRAD CHI MED(00570) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}